Vitiligo-like depigmentation in patients receiving programmed cell death-1 inhibitor reflects active vitiligo.
Fukuda K, Harris JE. Vitiligo-like depigmentation in patients receiving programmed cell death-1 inhibitor reflects active vitiligo. J Am Acad Dermatol. 2018 01; 78(1):e15-e16.